‘ZS-MDR-TB' versus ‘ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility

‘ZS-MDR-TB' versus ‘ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility

Indispensable for shortening treatment of drug-susceptible tuberculosis (TB), pyrazinamide (PZA, Z) is also essential in the treatment of multidrug-resistant (MDR)-TB. While resistance to PZA in MDR-TB is associated with poor treatment outcome, bacillary susceptibility to PZA along with the use of f...

Full description

Bibliographic Details
Main Authors: Zhang, Ying, Chiu Chang, Kwok, Leung, Chi-Chiu, Wai Yew, Wing, Gicquel, Brigitte, Fallows, Dorothy, Kaplan, Gilla, Chaisson, Richard E, Zhang, Wenhong
Format: Online
Language:English
Published: Nature Publishing Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630910/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630910/

Similar Items